Panacea Biotec
by Anshuman MiraniPanacea or cure-all refers to an invigorating force, something
that is like the elixir of life. Anyone drinking it will be blessed with a disease
free life and immortality.
True to this meaning is Panacea Biotec, which has touched the lives of millions
and millions of Indians and its never ceasing efforts ensuring that it will
help billions more.
Based in Delhi, Lalru in Punjab as well as Navi Mumbai, Panacea is an essential
cog in the wheel of Indian Biotechnology and penetrates the Indian markets.
In a country such as India, the affordability of health care products is very
essential. It is a simple mathematical problem, people can only buy in proportion
to what they earn and hence, cheaper and more affordable medicines are needed
in our country. Panacea emerges as a leader in this regard without sacrificing
on the product quality.
Panacea Biotec is India’s frontline research based health management company involved in research, manufacturing and marketing of pharmaceuticals, biopharmaceuticals, new chemical entities, natural products and vaccines.
The continuous processes of Innovation, learning, quality and productivity
has led to the recognition of Panacea in the industry and accordingly it has
been ranked amongst the top 3 biotechnology companies in India .
The product portfolio includes highly innovative prescription products in important
therapeutic areas like pain management, diabetes & cardiovascular management,
renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal
care products and vaccines.
Research & Development
Ardent Research and Development efforts have always been a great strength of
Panacea Biotec. The company has spent 6.14 % of it's net sales on R&D last
year, an increase of 34 % over previous year. The increased R&D expenditure
is in line with the company’s strategy of expanding its scientific strength
by working tirelessly to find novel therapies and drug delivery systems aimed
to establish leadership in target segments.
Panacea Biotec is ranked 6th among pharmaceutical companies in India by ET 500 for its spending ratio on R&D.
In the field of Vaccines , Panacea Biotec has to its credit development of Monovalent Type 1 Oral Polio Vaccine ( mOPV1 ) in addition to the conventional Trivalent Oral Polio Vaccine and new innovative Combination Vaccines.
Careers
Panacea Biotec is a leading research based Health Management Company,
with an annual turnover of approx. Rs. 536 Crore for the year 2005-06. It has
recorded a remarkable performance during quarter & nine months ended 31st
December 2006 and achieved a record turnover of Rs. 6112.2 million.
Young, intelligent and performing individuals are always welcomed and rewarded
at Panacea.
For current openings at Panacea, please visit http://www.panacea-biotec.com/career/career.htm
For any further information, please visit http://www.panacea-biotec.com/
April 2007, Jeev
http://www.dce.edu/jeev
This work is licensed under a Creative Commons Attribution 2.5 License.